Hospira, Inc.  

(Public, NYSE:HSP)   Watch this stock  
Find more results for William G. Kaufman�
42.84
-0.16 (-0.37%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 42.51 - 43.22
52 week 30.86 - 45.24
Open 42.85
Vol / Avg. 620,492.00/1.25M
Mkt cap 7.13B
P/E     -
Div/yield     -
EPS -0.05
Shares 166.46M
Beta 0.57
Inst. own 91%
May 7, 2014
Hospira Annual Meeting of Shareholders - 12:00PM EDT - Add to calendar
Apr 30, 2014
Q1 2014 Hospira Earnings Release - 9:30AM EDT - Add to calendar
Apr 30, 2014
Q1 2014 Hospira Earnings Conference Call - 9:00AM EDT - Add to calendar
Mar 12, 2014
Hospira at Barclays Healthcare Conference - Webcast
Mar 4, 2014
Hospira at Raymond James Institutional Investors Conference - Webcast
Feb 12, 2014
Q4 2013 Hospira Earnings Release
Feb 12, 2014
Q4 2013 Hospira Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 2.73% -0.62%
Operating margin 4.91% -0.78%
EBITD margin - 7.34%
Return on average assets 1.94% -0.41%
Return on average equity 4.58% -0.28%
Employees 17,000 -
CDP Score - 50 E

Address

275 North Field Drive
LAKE FOREST, IL 60045
United States - Map
+1-847-9376472 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hospira, Inc. (Hospira) is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of products, including specialty injectable and other pharmaceuticals and medication management products.

Officers and directors

F. Michael Ball Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Thomas E. Werner Chief Financial Officer, Senior Vice President - Finance
Age: 56
Bio & Compensation  - Reuters
David J. Endicott President, Hospira Medical Devices
Age: 49
Bio & Compensation  - Reuters
Daphne E. Jones Chief Information Officer, Senior Vice President
Age: 56
Bio & Compensation  - Reuters
Sumant Ramachandra M.D., Ph.D. Senior Vice President, Chief Scientific Officer
Age: 45
Bio & Compensation  - Reuters
Richard John Davies Senior Vice President, Chief Commercial Officer
Age: 52
Bio & Compensation  - Reuters
John B. Elliot Senior Vice President - International Pharmaceutical Operations
Age: 62
Bio & Compensation  - Reuters
Zena G. Kaufman Senior Vice President - Quality
Age: 57
Bio & Compensation  - Reuters
Kenneth F. Meyers Senior Vice President - Organizational Transformation and People Development
Age: 52
Bio & Compensation  - Reuters
Brian J. Smith Senior Vice President, Chief Legal Officer
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance